Table 3.
GO Terms for NP subpopulations
| Efector NPCs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0016126 | sterol biosynthetic process | 2.432 × 10−11 |
| GO:0006695 | cholesterol biosynthetic process | 5.795 × 10−10 |
| GO:0030198 | extracellular matrix organization | 3.136 × 10−8 |
| GO:0044281 | small molecule metabolic process | 4.528 × 10−8 |
| GO:0001558 | regulation of cell growth | 2.285 × 10−6 |
| GO:0001501 | skeletal system development | 3.133 × 10−6 |
| GO:0006694 | steroid biosynthetic process | 5.308 × 10−6 |
| GO:0008203 | cholesterol metabolic process | 9.283 × 10−6 |
| GO:0008202 | steroid metabolic process | 1.061 × 10−5 |
| GO:0006048 | UDP‐N‐acetylglucosamine biosynthetic process | 1.904 × 10−5 |
| GO:0008299 | isoprenoid biosynthetic process | 2.17 × 10−5 |
| GO:0010628 | positive regulation of gene expression | 3.007 × 10−5 |
| GO:0008285 | negative regulation of cell proliferation | 3.96 × 10−5 |
| GO:0009405 | pathogenesis | 5.295 × 10−5 |
| GO:0072593 | reactive oxygen species metabolic process | 6.08 × 10−5 |
| GO:0006629 | lipid metabolic process | 9.184 × 10−5 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 9.297 × 10−5 |
| GO:0033173 | calcineurin‐NFAT signaling cascade | 0.0001037 |
| GO:0030199 | collagen fibril organization | 0.0001053 |
| GO:0042127 | regulation of cell proliferation | 0.0001366 |
| GO:0001525 | angiogenesis | 0.0001439 |
| GO:0014070 | response to organic cyclic compound | 0.0001497 |
| GO:0010955 | negative regulation of protein processing | 0.0001541 |
| GO:0042340 | keratan sulfate catabolic process | 0.0001541 |
| GO:0006011 | UDP‐glucose metabolic process | 0.0001563 |
| GO:0007568 | aging | 0.0001871 |
| GO:0006633 | fatty acid biosynthetic process | 0.0002058 |
| GO:0043434 | response to peptide hormone | 0.000223 |
| GO:0055114 | oxidation‐reduction process | 0.0002321 |
| GO:0005975 | carbohydrate metabolic process | 0.0003237 |
| GO:0043065 | positive regulation of apoptotic process | 0.0003622 |
| GO:0030203 | glycosaminoglycan metabolic process | 0.0003728 |
| GO:0043066 | negative regulation of apoptotic process | 0.000445 |
| GO:0003331 | positive regulation of extracellular matrix constituent secretion | 0.0004652 |
| GO:0006065 | UDP‐glucuronate biosynthetic process | 0.0004652 |
| GO:2000544 | regulation of endothelial cell chemotaxis to fibroblast growth factor | 0.0004652 |
| GO:0042542 | response to hydrogen peroxide | 0.0004732 |
| GO:0032270 | positive regulation of cellular protein metabolic process | 0.0005055 |
| GO:0006915 | apoptotic process | 0.0006357 |
| GO:0010035 | response to inorganic substance | 0.0006375 |
| GO:0008284 | positive regulation of cell proliferation | 0.0006802 |
| GO:0044255 | cellular lipid metabolic process | 0.0007222 |
| GO:0060591 | chondroblast differentiation | 0.0009226 |
| GO:1903169 | regulation of calcium ion transmembrane transport | 0.0009226 |
| GO:0006933 | negative regulation of cell adhesion involved in substrate‐bound cell migration | 0.0009226 |
| GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway | 0.0009226 |
| GO:0009314 | response to radiation | 0.0009242 |
| GO:0060291 | long‐term synaptic potentiation | 0.0010297 |
| GO:0045444 | fat cell differentiation | 0.0013192 |
| GO:0031394 | positive regulation of prostaglandin biosynthetic process | 0.001525 |
| FibroNPCs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0030198 | extracellular matrix organization | 8.663 × 10−42 |
| GO:0007155 | cell adhesion | 9.642 × 10−28 |
| GO:0022617 | extracellular matrix disassembly | 1.776 × 10−23 |
| GO:0030574 | collagen catabolic process | 5.312 × 10−19 |
| GO:0007411 | axon guidance | 2.226 × 10−16 |
| GO:0030199 | collagen fibril organization | 8.14 × 10−16 |
| GO:0001525 | angiogenesis | 1.304 × 10−12 |
| GO:0002576 | platelet degranulation | 1.732 × 10−11 |
| GO:0030168 | platelet activation | 9.024 × 10−11 |
| GO:0007507 | heart development | 1.504 × 10−10 |
| GO:0006928 | cellular component movement | 2.848 × 10−10 |
| GO:0007596 | blood coagulation | 2.876 × 10−9 |
| GO:0008285 | negative regulation of cell proliferation | 7.397 × 10−9 |
| GO:0016477 | cell migration | 3.908 × 10−7 |
| GO:0001558 | regulation of cell growth | 4.529 × 10−7 |
| GO:0009612 | response to mechanical stimulus | 6.42 × 10−7 |
| GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.441 × 10−6 |
| GO:0051017 | actin filament bundle assembly | 1.628 × 10−6 |
| GO:0001649 | osteoblast differentiation | 2.019 × 10−6 |
| GO:0001666 | response to hypoxia | 2.039 × 10−6 |
| GO:0008283 | cell proliferation | 2.174 × 10−6 |
| GO:0035987 | endodermal cell differentiation | 3.631 × 10−6 |
| GO:0007162 | negative regulation of cell adhesion | 3.942 × 10−6 |
| GO:0007160 | cell‐matrix adhesion | 4.348 × 10−6 |
| GO:0030336 | negative regulation of cell migration | 4.63 × 10−6 |
| GO:0051764 | actin crosslink formation | 5.041 × 10−6 |
| GO:0071230 | cellular response to amino acid stimulus | 5.525 × 10−6 |
| GO:0050900 | leukocyte migration | 6.418 × 10−6 |
| GO:0048013 | ephrin receptor signaling pathway | 7.117 × 10−6 |
| GO:0030335 | positive regulation of cell migration | 7.697 × 10−6 |
| GO:0001974 | blood vessel remodeling | 8.644 × 10−6 |
| GO:0016525 | negative regulation of angiogenesis | 9 × 10−6 |
| GO:0001501 | skeletal system development | 9.137 × 10−6 |
| GO:0071305 | cellular response to vitamin D | 1.097 × 10−5 |
| GO:0010811 | positive regulation of cell‐substrate adhesion | 1.102 × 10−5 |
| GO:0045669 | positive regulation of osteoblast differentiation | 1.291 × 10−5 |
| GO:0048813 | dendrite morphogenesis | 1.394 × 10−5 |
| GO:0051493 | regulation of cytoskeleton organization | 1.57 × 10−5 |
| GO:0042060 | wound healing | 1.585 × 10−5 |
| GO:0009611 | response to wounding | 1.821 × 10−5 |
| GO:0006936 | muscle contraction | 2.038 × 10−5 |
| GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 2.151 × 10−5 |
| GO:0043491 | protein kinase B signaling | 2.758 × 10−5 |
| GO:0046718 | viral entry into host cell | 3.305 × 10−5 |
| GO:0001938 | positive regulation of endothelial cell proliferation | 3.468 × 10−5 |
| GO:0032964 | collagen biosynthetic process | 3.531 × 10−5 |
| GO:0060674 | placenta blood vessel development | 3.762 × 10−5 |
| GO:0031532 | actin cytoskeleton reorganization | 5.90377 × 10−5 |
| GO:0006898 | receptor‐mediated endocytosis | 6.00706 × 10−5 |
| GO:0030036 | actin cytoskeleton organization | 6.00706 × 10−5 |
| Homestatic NPs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0006614 | SRP‐dependent cotranslational protein targeting to membrane | 2.963 × 10−89 |
| GO:0006415 | translational termination | 4.999 × 10−86 |
| GO:0006414 | translational elongation | 7.153 × 10−80 |
| GO:0019083 | viral transcription | 1.067 × 10−76 |
| GO:0006412 | translation | 1.077 × 1076 |
| GO:0000184 | nuclear‐transcribed mRNA catabolic process, nonsense‐mediated decay | 5.322 × 10−75 |
| GO:0019058 | viral life cycle | 9.812 × 10−75 |
| GO:0006413 | translational initiation | 1.227 × 10−74 |
| GO:0016070 | RNA metabolic process | 1.437 × 10−71 |
| GO:0016071 | mRNA metabolic process | 3.898 × 10−67 |
| GO:0010467 | gene expression | 9.55 × 10−63 |
| GO:0016032 | viral process | 4.056 × 10−53 |
| GO:0044267 | cellular protein metabolic process | 3.626 × 10−47 |
| GO:0022904 | respiratory electron transport chain | 2.26 × 10−21 |
| GO:0044237 | cellular metabolic process | 1.722 × 10−18 |
| GO:0002181 | cytoplasmic translation | 5.217 × 10−15 |
| GO:0042274 | ribosomal small subunit biogenesis | 1.254 × 10−11 |
| GO:0000027 | ribosomal large subunit assembly | 1.824 × 10−11 |
| GO:0000028 | ribosomal small subunit assembly | 2.147 × 10−10 |
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP‐dependent | 1.431 × 10−9 |
| GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.655 × 10−9 |
| GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1.106 × 10−8 |
| GO:0006364 | rRNA processing | 1.348 × 10−8 |
| GO:1902600 | hydrogen ion transmembrane transport | 1.963 × 10−8 |
| GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.211 × 10−8 |
| GO:0051437 | positive regulation of ubiquitin‐protein ligase activity involved in mitotic cell cycle | 2.365 × 10−8 |
| GO:0051439 | regulation of ubiquitin‐protein ligase activity involved in mitotic cell cycle | 4.824 × 10−8 |
| GO:0000398 | mRNA splicing, via spliceosome | 5.565 × 10−8 |
| GO:0051436 | negative regulation of ubiquitin‐protein ligase activity involved in mitotic cell cycle | 9.745 × 10−8 |
| GO:0038061 | NIK/NF‐kappaB signaling | 1.169 × 10−7 |
| GO:0031145 | anaphase‐promoting complex‐dependent proteasomal ubiquitin‐dependent protein catabolic process | 1.282 × 10−7 |
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.331 × 10−7 |
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8.067 × 10−7 |
| GO:0033209 | tumor necrosis factor‐mediated signaling pathway | 9.747 × 10−7 |
| GO:0000387 | spliceosomal snRNP assembly | 2.742 × 10−6 |
| GO:0034660 | ncRNA metabolic process | 4.53 × 10−6 |
| GO:0006521 | regulation of cellular amino acid metabolic process | 5.739 × 10−6 |
| GO:0050434 | positive regulation of viral transcription | 6.873 × 10−6 |
| GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 1.66 × 10−5 |
| GO:0044281 | small molecule metabolic process | 1.913 × 10−5 |
| GO:0006446 | regulation of translational initiation | 2.391 × 10−5 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 2.8 × 10−5 |
| GO:0010499 | proteasomal ubiquitin‐independent protein catabolic process | 3.292 × 10−5 |
| GO:0019068 | virion assembly | 3.292 × 10−5 |
| GO:0000209 | protein polyubiquitination | 3.844 × 10−5 |
| GO:0042254 | ribosome biogenesis | 4.293 × 10−5 |
| GO:0001731 | formation of translation preinitiation complex | 4.472 × 10−5 |
| GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.798 × 10−5 |
| GO:0021888 | hypothalamus gonadotrophin‐releasing hormone neuron development | 4.944 × 10−5 |
| GO:0002223 | stimulatory C‐type lectin receptor signaling pathway | 5.147 × 10−5 |
| HT‐CLNPs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0043066 | negative regulation of apoptotic process | 9.969 × 10−11 |
| GO:0044267 | cellular protein metabolic process | 1.093 × 10−9 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.504 × 10−9 |
| GO:0006413 | translational initiation | 2.324 × 10−9 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.996E‐09 |
| GO:0006366 | transcription from RNA polymerase II promoter | 4.917 × 10−9 |
| GO:0010467 | gene expression | 1.639 × 10−7 |
| GO:0007623 | circadian rhythm | 3.873 × 10−7 |
| GO:0001501 | skeletal system development | 4.605 × 10−7 |
| GO:1901653 | cellular response to peptide | 8.175 × 10−7 |
| GO:0043065 | positive regulation of apoptotic process | 1.082 × 10−6 |
| GO:0007179 | transforming growth factor beta receptor signaling pathway | 4.329 × 10−6 |
| GO:0009409 | response to cold | 6.217 × 10−6 |
| GO:0006986 | response to unfolded protein | 6.218 × 10−6 |
| GO:0006446 | regulation of translational initiation | 7.305 × 10−6 |
| GO:0006412 | translation | 8.13 × 10−6 |
| GO:0016071 | mRNA metabolic process | 8.787 × 10−6 |
| GO:0009612 | response to mechanical stimulus | 1.109 × 10−5 |
| GO:0032496 | response to lipopolysaccharide | 1.285 × 10−5 |
| GO:0008284 | positive regulation of cell proliferation | 2.057 × 10−5 |
| GO:0035914 | skeletal muscle cell differentiation | 2.28 × 10−5 |
| GO:0071479 | cellular response to ionizing radiation | 2.342 × 10−5 |
| GO:0014070 | response to organic cyclic compound | 2.375 × 10−5 |
| GO:0030968 | endoplasmic reticulum unfolded protein response | 2.616 × 10−5 |
| GO:0070301 | cellular response to hydrogen peroxide | 4.16 × 10−5 |
| GO:0006415 | translational termination | 5.61 × 10−5 |
| GO:0006414 | translational elongation | 6.171 × 10−5 |
| GO:0006355 | regulation of transcription, DNA‐templated | 7.051 × 10−5 |
| GO:0006351 | transcription, DNA‐templated | 7.28 × 10−5 |
| GO:0006457 | protein folding | 7.913 × 10−5 |
| GO:0051726 | regulation of cell cycle | 8.277 × 10−5 |
| GO:0042493 | response to drug | 8.474 × 10−5 |
| GO:0010501 | RNA secondary structure unwinding | 9.475 × 10−5 |
| GO:0006915 | apoptotic process | 9.491 × 10−5 |
| GO:0006950 | response to stress | 9.576 × 10−5 |
| GO:0034097 | response to cytokine | 0.0001053 |
| GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 0.0001053 |
| GO:0071499 | cellular response to laminar fluid shear stress | 0.0001053 |
| GO:0000398 | mRNA splicing, via spliceosome | 0.0001095 |
| GO:0048705 | skeletal system morphogenesis | 0.0001226 |
| GO:0071353 | cellular response to interleukin‐4 | 0.0001237 |
| GO:0016070 | RNA metabolic process | 0.0001291 |
| GO:0043433 | negative regulation of sequence‐specific DNA binding transcription factor activity | 0.0001513 |
| GO:0002486 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP‐independent | 0.000158 |
| GO:0045892 | negative regulation of transcription, DNA‐templated | 0.0001617 |
| GO:0048662 | negative regulation of smooth muscle cell proliferation | 0.0002132 |
| GO:0008380 | RNA splicing | 0.0002219 |
| GO:0043434 | response to peptide hormone | 0.0002296 |
| GO:0021762 | substantia nigra development | 0.0002719 |
| GO:0034976 | response to endoplasmic reticulum stress | 0.00029 |
| Adhesion NPs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0030198 | extracellular matrix organization | 1.294 × 10−17 |
| GO:0007155 | cell adhesion | 2.035 × 10−10 |
| GO:0030199 | collagen fibril organization | 2.478 × 10−9 |
| GO:0001501 | skeletal system development | 8.734 × 10−9 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.663 × 10−8 |
| GO:0022617 | extracellular matrix disassembly | 3.188 × 10−7 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.322 × 10−7 |
| GO:0030574 | collagen catabolic process | 1.183 × 10−6 |
| GO:0007050 | cell cycle arrest | 1.66 × 10−6 |
| GO:0035987 | endodermal cell differentiation | 7.714 × 10−6 |
| GO:0007179 | transforming growth factor beta receptor signaling pathway | 8.171 × 10−6 |
| GO:0001525 | angiogenesis | 1.4 × 10−5 |
| GO:0001568 | blood vessel development | 1.842 × 10−5 |
| GO:0006865 | amino acid transport | 2.386 × 10−5 |
| GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.834 × 10−5 |
| GO:0045444 | fat cell differentiation | 4.298 × 10−5 |
| GO:0048146 | positive regulation of fibroblast proliferation | 5.614 × 10−5 |
| GO:0006366 | transcription from RNA polymerase II promoter | 5.619 × 10−5 |
| GO:0043001 | Golgi to plasma membrane protein transport | 6.09 × 10−5 |
| GO:0003007 | heart morphogenesis | 6.397 × 10−5 |
| GO:0014912 | negative regulation of smooth muscle cell migration | 6.773 × 10−5 |
| GO:0003333 | amino acid transmembrane transport | 7.054 × 10−5 |
| GO:1902966 | positive regulation of protein localization to early endosome | 7.632 × 10−5 |
| GO:0001503 | ossification | 0.000107 |
| GO:0045599 | negative regulation of fat cell differentiation | 0.0001124 |
| GO:0048705 | skeletal system morphogenesis | 0.0001124 |
| GO:0032956 | regulation of actin cytoskeleton organization | 0.00013 |
| GO:0046825 | regulation of protein export from nucleus | 0.0001504 |
| GO:0061028 | establishment of endothelial barrier | 0.0001781 |
| GO:0043277 | apoptotic cell clearance | 0.0001781 |
| GO:0007219 | Notch signaling pathway | 0.0001879 |
| GO:0010628 | positive regulation of gene expression | 0.0002892 |
| GO:0050919 | negative chemotaxis | 0.000301 |
| GO:0048008 | platelet‐derived growth factor receptor signaling pathway | 0.0003392 |
| GO:0008284 | positive regulation of cell proliferation | 0.0003679 |
| GO:0048593 | camera‐type eye morphogenesis | 0.0003809 |
| GO:0060325 | face morphogenesis | 0.0003956 |
| GO:0035989 | tendon development | 0.0003967 |
| GO:0071709 | membrane assembly | 0.0003967 |
| GO:1903225 | negative regulation of endodermal cell differentiation | 0.0003967 |
| GO:0030335 | positive regulation of cell migration | 0.0003991 |
| GO:0002053 | positive regulation of mesenchymal cell proliferation | 0.0004587 |
| GO:0030154 | cell differentiation | 0.0004762 |
| GO:0060021 | palate development | 0.0004797 |
| GO:0007229 | integrin‐mediated signaling pathway | 0.0005359 |
| GO:0045893 | positive regulation of transcription, DNA‐templated | 0.0005761 |
| GO:0042340 | keratan sulfate catabolic process | 0.0006041 |
| GO:0051216 | cartilage development | 0.0006198 |
| Regulatory NPCs GO terms | ||
|---|---|---|
| GOID | GOTerm | P‐value |
| GO:0006954 | inflammatory response | 4.936 × 10−13 |
| GO:0071294 | cellular response to zinc ion | 3.004 × 10−9 |
| GO:0045926 | negative regulation of growth | 9.96 × 10−9 |
| GO:0035666 | TRIF‐dependent toll‐like receptor signaling pathway | 2 × 10−8 |
| GO:0071222 | cellular response to lipopolysaccharide | 2.027 × 10−8 |
| GO:0002756 | MyD88‐independent toll‐like receptor signaling pathway | 2.248 × 10−8 |
| GO:0034138 | toll‐like receptor 3 signaling pathway | 3.161 × 10−8 |
| GO:0034142 | toll‐like receptor 4 signaling pathway | 1.434 × 10−7 |
| GO:0071276 | cellular response to cadmium ion | 1.933 × 10−7 |
| GO:0032496 | response to lipopolysaccharide | 3.658 × 10−7 |
| GO:0002224 | toll‐like receptor signaling pathway | 4.694 × 10−7 |
| GO:0010628 | positive regulation of gene expression | 5.726 × 10−7 |
| GO:0034166 | toll‐like receptor 10 signaling pathway | 1.709 × 10−6 |
| GO:0034146 | toll‐like receptor 5 signaling pathway | 1.709 × 10−6 |
| GO:0048711 | positive regulation of astrocyte differentiation | 1.771 × 10−6 |
| GO:0008285 | negative regulation of cell proliferation | 1.972 × 10−6 |
| GO:0038124 | toll‐like receptor TLR6:TLR2 signaling pathway | 3.095 × 10−6 |
| GO:0038123 | toll‐like receptor TLR1:TLR2 signaling pathway | 3.095 × 10−6 |
| GO:0034162 | toll‐like receptor 9 signaling pathway | 3.398 × 10−6 |
| GO:0034134 | toll‐like receptor 2 signaling pathway | 3.726 × 10−6 |
| GO:0006915 | apoptotic process | 3.786 × 10−6 |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4.314 × 10−6 |
| GO:0070301 | cellular response to hydrogen peroxide | 5.255 × 10−6 |
| GO:0002755 | MyD88‐dependent toll‐like receptor signaling pathway | 6.844 × 10−6 |
| GO:0071356 | cellular response to tumor necrosis factor | 1.02 × 10−5 |
| GO:0014070 | response to organic cyclic compound | 1.168 × 10−5 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.242 × 10−5 |
| GO:0071347 | cellular response to interleukin‐1 | 1.37 × 10−5 |
| GO:0009612 | response to mechanical stimulus | 1.508 × 10−5 |
| GO:0045600 | positive regulation of fat cell differentiation | 2.168 × 10−5 |
| GO:0043066 | negative regulation of apoptotic process | 2.473 × 10−5 |
| GO:0033138 | positive regulation of peptidyl‐serine phosphorylation | 3.34 × 10−5 |
| GO:0007249 | I‐kappaB kinase/NF‐kappaB signaling | 3.948 × 10−5 |
| GO:0006955 | immune response | 4.057 × 10−5 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.431 × 10−5 |
| GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 4.914 × 10−5 |
| GO:0043123 | positive regulation of I‐kappaB kinase/NF‐kappaB signaling | 4.956 × 10−5 |
| GO:0060546 | negative regulation of necroptotic process | 5.314 × 10−5 |
| GO:2000116 | regulation of cysteine‐type endopeptidase activity | 7.62 × 10−5 |
| GO:0002246 | wound healing involved in inflammatory response | 7.62 × 10−5 |
| GO:0039535 | regulation of RIG‐I signaling pathway | 7.62 × 10−5 |
| GO:0036018 | cellular response to erythropoietin | 7.62 × 10−5 |
| GO:0070427 | nucleotide‐binding oligomerization domain containing 1 signaling pathway | 7.62 × 10−5 |
| GO:0002237 | response to molecule of bacterial origin | 0.000103 |
| GO:0051403 | stress‐activated MAPK cascade | 0.0001277 |
| GO:0045651 | positive regulation of macrophage differentiation | 0.0001365 |
| GO:0070555 | response to interleukin‐1 | 0.0001673 |
| GO:0010243 | response to organonitrogen compound | 0.0001673 |
| GO:0032743 | positive regulation of interleukin‐2 production | 0.0001763 |
| GO:0006953 | acute‐phase response | 0.0002129 |